DOT drug testsordered in minutes.MRO‑reviewed.

Any CDL driver operating a commercial motor vehicle (CMV) in a safety‑sensitive function for an FMCSA‑regulated carrier must be enrolled in a DOT‑compliant drug and alcohol testing program. This includes owner‑operators who drive their own trucks. Safety‑sensitive functions include driving, loading and securing cargo, fueling, inspecting, or repairing a CMV.

The DOT‑mandated 5‑panel urine drug test screens for marijuana (THC metabolites), cocaine, amphetamines (including methamphetamine and MDMA), opioids (codeine, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, plus 6‑acetylmorphine — the heroin metabolite), and phencyclidine (PCP). The expanded opioid panel has been in effect since the 2017 HHS Mandatory Guidelines update. Specimen collection and chain‑of‑custody procedures follow strict HHS/SAMHSA standards. All results are reviewed by a DOT‑certified Medical Review Officer (MRO) before being reported to the employer.

A positive result triggers a DOT‑defined return‑to‑duty process. The driver must be immediately removed from all safety‑sensitive functions. They must be evaluated by a DOT‑qualified Substance Abuse Professional (SAP), complete the SAP‑recommended education or treatment, pass a return‑to‑duty drug test with a verified negative, and complete a follow‑up testing schedule — minimum 6 unannounced tests in the first 12 months. The violation is also reported to the FMCSA Clearinghouse. We coordinate the entire RTD process and track follow‑up tests.

Lab results are routed first to the DOT‑qualified Medical Review Officer (MRO) for verification. The MRO contacts the donor on positives to confirm any prescription explanations. Once the result is finalized, we push it to you electronically as a PDF — ready to drop into the Driver Qualification file. Result timing depends on the lab and the MRO process, both of which sit outside our control; we surface the result the moment it’s available.

No. Our individual drug test ordering service is used to order specific tests — pre‑employment, post‑accident, reasonable suspicion, RTD, or follow‑up. For the mandatory random testing program under 49 CFR Part 382, you must be enrolled in a DOT random testing consortium. Trucking Comply offers a separate DOT Random Testing Consortium membership that covers random selections, MRO fees, policy, and annual MIS filing. Individual drug test orders supplement but do not replace consortium enrollment.

No. Non‑DOT tests do not follow 49 CFR Part 40 procedures, are not conducted at HHS‑certified sites, and are not reviewed by a certified MRO. They cannot be used to satisfy any FMCSA drug testing requirement, including pre‑employment, post‑accident, or random. Using a non‑DOT test when a DOT test is required is itself a violation.

Chain‑of‑custody (COC) is the documented process that tracks a urine specimen from the moment of collection to final MRO review. Under 49 CFR Part 40, every DOT test requires a federal CCF (Custody and Control Form) to document collection, splits, shipping, lab receipt, and MRO review. Breaks in the COC chain can invalidate a test result, create compliance gaps, and expose you to audit findings. Our process ensures a proper electronic CCF is generated for every test.

Yes. FMCSA regulations require a verified negative pre‑employment drug test result before a CDL driver operates a CMV for your company. There is one exception: if the driver is enrolled in a DOT random testing program administered by another employer, and you receive written documentation of that enrollment, and the driver has not had a gap in DOT‑regulated employment greater than 30 days — then you may request a previous employer verification in lieu of a new test. In most practical hiring scenarios, a new pre‑employment test is the safest and cleanest path.